医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2024年美国移植大会(ATC)
     
 

◆ 会议时间:2024年6月1日至5日
◆ 会议地点:美国 费城

 

◆ 会议简介:

2024年美国移植大会/年会(ATC)将于2024年6月1日至5日在美国宾夕法尼亚州费城举行。

美国移植大会(ATC)是美国移植外科医师学会(ASTS)和美国移植学会(AST)的联合年会。ATC是基础和临床移植领域最重要的教育活动,每年都有4000多名医师、外科医生、科学家、护士、器官采购人员、药剂师和其他对实体器官和组织移植的临床和研究方面感兴趣的专业人士与会。

美国移植外科医师学会(ASTS)成立于1974年,代表着大约1800名专业从事移植外科工作的专业人士,使命是通过领导、倡导、教育和培训来推进移植外科的艺术和科学。

美国移植学会(AST)成立于1982年,是北美地区最大、全球首屈一指的器官移植专业组织,致力于通过促进研究、教育、宣传和器官捐献来推动该领域宣的发展和改善对患者的护理,现在全球拥有超过3500名成员。其他移植组织、政策制定者、监管机构、需求者、学术机构和公众都向AST寻求有关移植方面的指导、研究和资源。未经许可禁止复制转载镜像本站任何内容—国际医学会议网(lingyuint.com)。

American Transplant Congress 2024
Date: June 1 - 5, 2024
Venue: Pennsylvania Convention Center, Philadelphia, PA, USA

The American Transplant Congress (ATC) is the joint annual meeting of the AST and the American Society of Transplant Surgeons (ASTS). AST and ASTS have partnered to offer this joint meeting since 2001.

The ATC is organized by a team separate from AST and ASTS staff, with input provided by AST and ASTS staff and leaders.

 

摘要征文投稿:

2024 Abstract Program

Call for Abstracts

  • October 31, 2023 - Abstract submission site opens.
  • December 18, 2023, 11:59 PM PT - Abstract submission deadline.
  • Mid-February 2024 - Original abstract status notifications will be sent. 

Late Breaking Abstracts

  • January 13, 2024 - Late breaking abstract submission site opens.
  • February 9, 2024, 11:59 PM PT - Late breaking abstract submission deadline.
  • Mid-March 2024 - Late breaking abstract status notifications will be sent.

点此提交摘要>>>Submit Abstract>>>

ATC 2024 ABSTRACT CATEGORIES

 

提交指南:

Abstract Policies & Guidelines

Previous Presentation of Abstracts

Abstracts will be considered for presentation if they have NOT been previously published as an article at the TIME OF SUBMISSION.

Abstract Preparation

Abstracts must conform exactly to the instructions provided for electronic submission (by the American Transplant Congress). Click here for the full instruction document. This document will also be available in the ATC Program User Portal.

Abstracts must be submitted in English and all presentations will be in English. The abstract character limit is 2,750 characters. The character count includes: Abstract Title, Abstract Structure, Authors/Institutions, Table (320 characters), and Figures (320 characters) and does NOT include spaces.

Publication

Abstracts accepted for oral or poster presentation will be published online in a supplement to the American Journal of Transplantation, the joint journal of the American Society of Transplant Surgeons and the American Society of Transplantation. Abstracts not accepted for presentation will not be published. Abstracts and program will also be posted prior to the meeting on the American Transplant Congress website. Please check this for official publication date.

Informed Consent

Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966:14:103) and must meet all of the requirements governing informed consent of the country in which the study was performed. Any transplant procedures performed must meet with the prevailing ethical standards.

Use of Animals

All studies involving the use of animals must conform to the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).

Employees of Commercial Interests

ATC recognizes that employees of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. In order to be compliant with the various continuing medical education regulatory bodies, abstracts submitted by employees of commercial interests should not include patient care recommendations. They should focus on the biology, physiology or physics and include content about the discovery process. Abstracts should avoid discussion of products, treatment or diagnostics.

Co-Author Approval

Ensure that all co-authors approve of the abstract submission, publication, and potential presentation.

Abstract Review

Abstracts will be blinded for peer review. Authors should be cautious in using institutional references in the body of the abstract. Do not put author names and/or affiliations in the body. Abstracts which include reference to authors or institutions will not be reviewed.

Changes to Abstract

You are able to edit your abstract until the submission deadline, December 18, 2023. After the submission deadline, December 18, 2023, no changes are allowed. Any corrections, withdrawals and/or changes will not be accepted after this date. Please note: the submission fee is final and non-refundable regardless of abstract edits or withdrawal.

Abstract Receipt Confirmation

You will receive an email confirmation within two business days of submitting your abstract.

If you submit on the deadline date and do not receive confirmation within two business days, please contact CTI Meeting Technology Technical Support at: atc@support.ctimeetingtech.com or 1.217.398.1792.

Author Disclosure

The submitting author is required to submit their disclosure.

Abstract Clinical Content Validation

All the recommendations involving clinical medicine in a activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in this activity in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

Abstract content should not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of CME, or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients. Abstracts containing advocacy of unscientific modalities of diagnosis or therapy will not be considered.

ATC Abstract Embargo Policy

In compliance with the Securities and Exchange Commission's Regulation FD (Fair Disclosure), the accepted abstracts are made available to the public on the ATC website in advance of the meeting. Thus, the first release of the abstracts is a public release on May 1, 2024. Coverage of additional research being presented at the annual meeting is under embargo until the date of presentation.

Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract. However, the ATC continues to require that information that goes beyond that contained within the abstract, e.g., discussion of the abstract done as part of a scientific presentation, is to be embargoed until the start of the scientific sessions. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate.

Journalists failing to abide by the embargo may have their press credentials revoked.

Payment

Payment will be displayed as 'CTI' on credit card statements.

Abstract Submission Fee

Submission Fees

A submission fee of $25 for ASTS and/or AST members (first OR last author) or $50 for non-members is required to submit each abstract.

For late breaking abstracts, a submission fee of $50 for ASTS and/or AST members (first OR last author) or $100 for non-members is required to submit each abstract.

  • In order to receive the ASTS/AST abstract submission member fee, you must log in to the ATC Program User Portal with the email associated with the first or last authors membership account.
  • Once you have logged in you will have the option to change the presenting author.
  • Please note the presenting author will be listed as the primary author and will receive all abstract communications.

Payment

An abstract submission is not complete until full payment has been submitted online through the ATC Program User Portal. Payment will be displayed as 'CTI' on credit card statements.

 


 

 

 

◆ 参会对象:移植外科医生,对移植感兴趣的各个领域的医生,协调员、护士、营养师,对移植感兴趣的普通外科医生和临床医生•移植科学家,营养和康复专家,移植药剂师,以及其他对移植感兴趣的相关专业人士等等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们